Targeted treatments for cervical cancer: a review

O Peralta-Zaragoza, VH Bermúdez-Morales… - OncoTargets and …, 2012 - Taylor & Francis
Cervical cancer is the second most common cause of cancer death in women worldwide
and the development of new diagnosis, prognostic, and treatment strategies merits special …

Prospects of molecularly-targeted therapies for cervical cancer treatment

A Carlos de Freitas… - Current drug …, 2015 - ingentaconnect.com
Cervical cancer is the third most common cancer among women worldwide and is
responsible for 275.000 deaths each year. The development of cervical cancer has been …

Human papillomavirus: current and future RNAi therapeutic strategies for cervical cancer

HS Jung, N Rajasekaran, W Ju, YK Shin - Journal of clinical medicine, 2015 - mdpi.com
Human papillomaviruses (HPVs) are small DNA viruses; some oncogenic ones can cause
different types of cancer, in particular cervical cancer. HPV-associated carcinogenesis …

Emerging drugs for the treatment of cervical cancer

A Serrano-Olvera, L Cetina, J Coronel… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Worldwide, most cervical cancer (CC) patients require the use of drug therapy
either adjuvant, concurrent with radiation or palliative. Areas covered: This review briefly …

New developments in the treatment of invasive cervical cancer

SS Im, BJ Monk - Obstetrics and Gynecology Clinics, 2002 - obgyn.theclinics.com
Worldwide, cervical cancer is one of the most common cancers in women [1]. About 450,000
women are diagnosed with cervical cancer each year around the world, and another …

[HTML][HTML] Cervical cancer therapies: Current challenges and future perspectives

CA Burmeister, SF Khan, G Schäfer, N Mbatani… - Tumour Virus …, 2022 - Elsevier
Cervical cancer is the fourth most common female cancer worldwide and results in over 300
000 deaths globally. The causative agent of cervical cancer is persistent infection with high …

Cervical cancer and HPV infection: ongoing therapeutic research to counteract the action of E6 and E7 oncoproteins

AM Almeida, JA Queiroz, F Sousa, Â Sousa - Drug discovery today, 2019 - Elsevier
Highlights•Human papillomavirus (HPV) has a primordial role in the development of cervical
cancer.•Therapies currently available for cervical cancer treatment are reviewed.•The …

[HTML][HTML] Emerging biological treatments for uterine cervical carcinoma

P Vici, L Mariani, L Pizzuti, D Sergi, L Di Lauro… - Journal of …, 2014 - ncbi.nlm.nih.gov
Cervical cancer is the third most common cancer worldwide, and the development of new
diagnosis, prognostic, and treatment strategies is a major interest for public health. Cisplatin …

Rational design for cervical cancer therapeutics: cellular and non-cellular based strategies on the horizon for recurrent, metastatic or refractory cervical cancer

JE Wolford, KS Tewari - Expert opinion on drug discovery, 2018 - Taylor & Francis
Introduction: Though cervical cytology, HPV DNA testing, and pre-invasive disease
management has significantly reduced the number of new diagnoses of cervical cancer …

Molecular approaches to cervical cancer therapy

LM Alvarez-Salas, JA DiPaolo - Current drug discovery …, 2007 - ingentaconnect.com
Cervical cancer is the second most common malignancy in women worldwide. Two HPV
strains, HPV-16 and 18, occur in the 70% of untreated cancers. Expression of viral …